Member Info for TotalWealth

Don't see your 500,000 Tricky - is your broker asleep?

You won't get 500,000 at 0.293 Tricky - trying upping your bid to 0.30p, then you'll probably get filled around 0.296p.

I'm not sure I'd want Reeves to tickle my anus Tricky - she might find Lord Lucan.

FJH1 - welcome on board.

True what you say about Singer/Archer, but "This is Money" have covered us (twice), and I suspect that as interest grows and the clinical trials move ever forward we'll be featured in the press, particularly the Sunday press as a possible "BUY" tip.

These things do take time to come to fruition as you'll appreciate in this line, but SVNS are what you could call "almost there", and bear in mind they haven['t had the massive upfront costs to bring their Ketamine based products to fruition, as they would from starting a novel drug.

A lot does hinge, of course, on the phase 3 trial being successful, but if it fails, as Tricky said it shouldn't really dent the sp as much as it would another company because everything we have in the pipeline is grossly undervalued by the markets to begin with.

What your buying in to, uniquely, is a company at an advanced stage in the process for the cost of literally other companies in the space that are just mere "start-ups", and are nowhere near the conclusion(s) that we are. Mr Market hasn't quite cottoned on to that yet, because at even 0.3p (£15.5m mcap) they are a giveaway, despite the recent increase in the share price.

Even Singer's 1.6p valuation I take with a different view. To me that's just the value of all our current projects, even if one of them gets approval and passes the trials (and there is no reason to suppose they all won't that target will be left way behind.

Dvh - don't you think that days like this, with hindsight, turn into the ones where buying is favoured? Normally when there is a temporary loss of interest it usually ends up afterwards in strong rises if you look back at price history of many up and coming companies.

These are normally the days that any predators or stake builders look for.

Keep an eye out for any large buys to give a clue. I could bet the farm on it.

I feel that it won't be long before a predator strikes. J&J aren't going to sit back for one.

Not saying it's nailed on, but our pipeline alone is potentially worth a factor of 5 of the current mcap here without any further clinical trial progress.

As was said by ThisisMoney - "watch this space".

Good find Llama - hopefully some of that will be winging it's way towards us.

Wookie - since the publication of the two notes, my view has always been that 1p is a "staging post", where we should be awaitng further announcements, and given the portfolio we have with the massive potential, 1.6p I view as current "fair value". If, however, the trials come good, and I've not doubt that clinical trial 3 will do leading to a potential partnership agreement, then with bid potential thrown in anything up to 5p is achieveable.

Only my personal view of course but I feel those are the important numbers going forward.

Looks like some of the Oberon sales are being picked up nicely.

There IS a 1,350,000 buy - I presume it was a "fat finger" trade then.

I must own up to doing the same once at a well known US brokers - it sent the Dow up around 10 points as well.

Needless to say, that was my career over there! Long long ago.

All sorts of possibilities Tricky - MM to MM?

Well, that little ray of hope didn't last long!

I wonder, was it originally a "fat-finger" trade for maybe 1,350,000? Surely nobody buys 13.5m and sells them again within an hour or so.

Or the beginnings of serious stake-building as a bid prelude eventually?

Well done Epic.

Every little helps !

Blimey Epic - I thought my broker was slow but your 343k isn't transacted by the look of it yet. Did you enter a "fill or kill"? They can be a bit notorious at times, especially around lunchtime.

No, but you could be paying more tomorrow, and a lot more in the very near future !

Read both the Archer and Singer notes again last night (anorak). My view is that once the phase-3 trials are announced successful, I think there is then a very good chance that someone will knock us out with a 2p bid.

I just see a vast head of steam building, especially given the success over the pond of J&J and SVNS will eventually be seen as a major threat.

Purely a personal view of course, no advice intended and DYOR, but I see the Archer note (1p) as a "staging post", and the Singer note (1.6p) as a price level once confirmation of success has been announced. That then triggers further events, which could all happen rather quickly.

Anyone else thinking along those lines?

100% spot on word for word Estuary.

I presume they've been the 5m seller then. This maybe the overhang from the fund raise at 0.13p, so nothing wrong with them taking a profit.

As each day ticks by it's a day nearer the positive newsflow we're waiting for.

Have to agree tricky - looks like they may have played a blinder, sucking out cheap stock ready to sell on back towards the 30's.

Even cleverer than Djokovic who has just won after being trounced 1-6 in the first set.